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Executive summary 
Doping behaviors are not uncommon in sport or certain types of exercise settings. Over the 
last two decades, there has been a growing interest in understanding the psychological 
mechanisms associated with doping behavior. As such, there is a need to summarize the 
evidence in the literature and identify demographic (e.g., sex, age) and psycho-social (e.g., 
attitudes, perceived norms) variables that are most strongly related to doping behaviors or 
intentions to engage in such behaviors. To this end, this report represents the first meta-
analytical (Hunter & Schmidt, 2004) review of available studies in the extant literature. The 
review aimed to collectively determine (i) the predictive factors of doping intentions and 
doping behavior, and (ii) identify moderator variables. A total of 63 studies, spanning 1990-
2013, containing 63 independent published and unpublished datasets from 18 countries were 
examined and included in an analysis using odds ratios, Pearson correlations, and Cohen’s d 
for combining study estimates. We found that factors such as the use of legal supplements, 
perceived social norms, and positive attitudes towards doping were the strongest positive 
correlates of doping intentions and behaviors. In contrast, factors such as morality and self-
efficacy to refrain from doping had the strongest negative association with both intentions 
and doping behaviors.  
The effects of potential moderators such as sex, publication status, and study design 
were also tested. Although different sizes of effect were found across distinct levels of 
moderators, all such effects were in the expected directions. Given that that the Theory of 
Planned Behavior (Ajzen, 1991; Fishbein & Cappella, 2006) has been the dominant 
framework in doping behavior research (e.g., Zelli et al. 2010; Lazuras et al. 2010; Goulet et 
al. 2010; Lucidi et al. 2008;), we used path analysis to test a TPB-based model of doping 
using the meta-analyzed correlations as input matrix. Our results suggested that attitudes and 
perceived norms (positively), and self-efficacy to refrain from doping (negatively) predicted 
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intentions to dope, and in turn predicted doping behaviors. A direct path from perceived 
norms to doping behaviors was also found, suggesting that perceptions of others’ behaviors 
may play a salient role in individuals’ doping behaviors. The findings of this meta-analysis 
provide an objective and concise synthesis of prior research on the psycho-social variables 
associated with doping behavior and indicate the stronger predictors of doping use. Overall, 
they highlight the need for a broader approach to anti-doping education. An approach which 
moves beyond curricula heavily skewed towards compliance and testing towards one that 
emphasize the social context of doping behavior via strength- and norm-based activities.
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Introduction 
Doping behaviors refer to the use of illegal performance enhancing drugs (PEDs) and 
methods to improve sporting performance (WADA, 2009). Anti-doping rules and regulations 
are founded upon the premise that doping use violates the rules of competition, the spirit of 
sport, and can lead to health risks in users (WADA, 2009). Nonetheless, doping behaviors are 
not uncommon across various levels of sport and exercise participation (Baron, Martin, & 
Magd, 2007; Pitsch & Emrich, 2011). For instance, in a study conducted in a gym setting, 
researchers showed that more than 10% of participants have engaged in doping behaviors 
(Dunn, Mazanov, & Sitharthan, 2009). Amongst competitive bodybuilders, the figures are as 
high as 77.8% (Blouin and Goldfield, 1995). Children, as young as 10 years old, have also 
reported engaging in doping behaviors (Faigenbaum, Zaichkowsky, Gardner, & Micheli, 
1998). In high performance sport, the prevalence statistics are wide ranging. In a study of 
German athletes only 0.2% self-reported doping, but this figure increased to 6.6% when the 
randomized response technique (RRT) was employed (Striegel, et al., 2010). Also employing 
the RRT, Pitsch and Emrich (2011) suggest the upper limit of the rate of dopers among squad 
athletes in Germany to be 35%. Critically, prevalence estimates appear higher than WADA’s 
annual positive test statistic of ~2% (WADA, 2009).  
Despite the resource-limited efforts of the World-Anti-Doping Agency (WADA), the 
International Olympic Committee (IOC) and global sports federations, doping in sport 
prevails. High profile cases including the exposure of the Bay Area Laboratory Co-operative 
scandal (BALCO; Fainaru-Wada & Williams, 2006), the Lance Armstrong affair (United 
States Anti-Doping Agency, 2012) and the damning Australian Crime Commission report 
(Australian Crime Commission, 2013), underscore the harsh reality that detection techniques 
are not keeping pace with developments in the pharmaceutical industry. Moreover, in a report 
to the WADA Executive Committee, former WADA president Dick Pound claims that anti-
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doping programs are failing (Working Group on the (in)effectiveness of testing, 2013). Thus, 
it seems that dopers remain a giant leap ahead of the testers. Therefore, in light of this 
situation - and the reach of doping beyond elite sport - preventive and educational action 
must be taken. 
Empirical evidence on psycho-social predictors of doping intentions and behavior has 
significantly increased over the last decade. As such, a number of facilitating and inhibiting 
doping-related factors at the personal and socio-contextual level (e.g., gender, achievement 
goal orientations, moral values, influence of others) have been identified to predict doping 
behavior. However, the vast majority of these studies have been correlational in design. For 
the very small number of interventions that have been developed to tackle doping use in sport 
and leisure the weighted average magnitude of the obtained differences between the 
intervention and control arms is not known. Petróczi and Aidman (2008) argued that doping 
use can be explained by the interplay between a person’s motivations, cognitions, beliefs, 
moral code, and moral influences.  
Many studies have adopted aspects of the Theory of Planned Behavior (TPB; Ajzen, 
1991; Fishbein & Cappella, 2006) to examine the psycho-social mechanisms that may lead to 
doping behaviors. The TPB, an extension of the theory of reasoned action (Ajzen & Fishbein, 
1980), incorporates personality factors and social influences in order to predict behavior and 
behavioral intentions. A limited number of psychosocial variables are specified in the model, 
namely 1) intention, 2) attitude, 3) subjective norm (SN), and 4) perceived behavioral control 
(PBC). Attitudes represent an individual’s positive or negative evaluations of performing the 
behavior in question, and, therefore reflect a personal disposition towards engaging in the 
behavior. SN are conceptualized as the pressure that individuals perceive from significant 
others to engage in the target behavior and, in turn, the individual’s motivation to comply 
with these perceived pressures. PBC represent one’s evaluation about their capabilities to 
P a g e  | 3 
 
adopt the behavior. As such, it may reflect obstacles encountered in past behavioral 
performances. Attitudes, SN and PBC are proposed to influence behavior through their 
influence on intentions. In this case, intentions would represent an individual’s immediate 
behavioral orientation to engaging in doping behavior and therefore reflect the individual’s 
motivation towards doping. Evidence from narrative and meta-analytic reviews indicate that 
the TPB is a useful model for predicting a range of behaviors and behavioral intentions 
(Armitage & Conner, 2001).  
Authors utilizing the TPB have reported the ability of doping attitudes and subjective 
norms to predict doping behavior (e.g., Goulet, Valois, Buist, & Cote, 2010; Lazuras, 
Barkoukis, Rodafinos, & Tzorbatzoudis, 2010; Lucidi et al., 2008; Wiefferink, Detmar, 
Coumans, Vogels, & Paulussen, 2008). Importantly, these studies have involved a variety of 
populations including elite athletes (Lazuras et al., 2010), gym users (Wiefferink et al., 2008), 
and adolescents (Lucidi et al., 2008; Zelli, Mallia, & Lucidi, 2010) suggesting that attitudes 
and subjective norms influence doping intentions and in turn doping behavior regardless of 
the type of athlete an individual represents.  
Researchers have also used constructs outside the TPB framework to explain doping 
behaviors. For example, Lucidi et al. (2008) measured participants’ moral disengagement (i.e., 
disassociating oneself from the moral implications of one’s unethical actions) and showed 
that it predicted doping intentions and behaviors. Barkoukis, Lazuras, Tsorbatzoudis, and 
Rodafinos (2011) found that athletes with high sportspersonship (e.g., prosocial attitudes and 
behaviors), autonomous motivation (i.e., motivation resulting from enjoyment or personal 
value) and mastery-oriented profiles (i.e., emphasis on personal improvement and effort) 
demonstrated lower doping intentions compared to those with low sportspersonship, 
controlled motivation and performance oriented ones. This reinforced an earlier finding by 
Donahue et al. (2006) which showed that different types of motivation may affect PED use 
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through sportspersonship. Similarly, Barkoukis et al. (2011) indicated that in both dopers and 
non-dopers proximal predictors, such as attitudes, norms and self-efficacy (belief in one’s 
skills and ability), mediated the effect of more distal predictors, such as achievement goals 
(i.e., one’s emphasis on individual or normative criteria to infer personal competence in 
achievement settings) and sportspersonship on performance enhancing substance use. Further, 
Goulet et al. (2010) and Zelli et al. (2010) found that justifications for using performance 
enhancing substances and moral obligations significantly predicted doping intentions among 
junior athletes. The aforementioned findings highlight that doping use is a complex issue that 
is affected by a variety of situational and personal variables. Researchers have also designed 
interventions to reduce doping behaviors in adolescents. For example, Elliot et al. (2008) 
designed an intervention consisting of eight 45-minute meetings held during sport team 
training in US high schools. Using a randomized control trial, they showed that the program 
significantly reduced drug use in participants one to three years after the students graduated 
from high school. However, the size of effect found was very small. 
To date, only one systematic literature review has been performed to synopsize the 
research findings in this area (Backhouse, McKenna, Robinson, & Atkin, 2007). Focusing on 
attitudes, values and beliefs towards doping, predictors and precipitating factors in doping 
and anti-doping education and prevention programs, the authors reviewed 103 articles. 
Studies examining attitudes towards doping were most common, with college, university and 
high school athletes dominating the sample. Only twenty-one studies examined correlates, 
determinants or risk factors associated with the use of PEDs in sport and most of those 
examined risk factors for anabolic steroid use amongst weight lifters or body builders. As 
such, this research bias limited the degree to which the findings from the Backhouse et al. 
review may be generalized to contribute to our understanding of PED use amongst athletes. 
Hence, there is a need to accumulate and quantify, controlling for sampling and 
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measurement error, existing evidence across empirical studies to identify the key predictors 
of doping, so that resources are designed to specifically target these risk factors. There is also 
a need to examine whether these predictors have the same effect on intentions and doping 
behaviors for participants of different sex, age, or other demographic/personal characteristics. 
Hence, a quantitative synthesis of available research findings in the literature is warranted. 
 
The Current Study 
In order to provide a quantitative/statistical synthesis of research findings in the literature, we 
conducted a meta-analysis of existing studies, with the aim to identify the strongest 
facilitators and inhibitors (admittedly in a correlational sense as most of the meta-analyzed 
studies used a correlational design) of doping intentions and behaviors. In addition to 
personal psychological (e.g., attitudes) and social-contextual factors (e.g., social norms), we 
examined the effects of demographic variables (e.g., sex and age) on doping intentions and 
behaviors. Although these factors may not have been specifically tested as predictors of 
doping in some of the meta-analyzed studies, there might be important implications for 
practice if the effect sizes associated with these variables are notable. We also meta-analyzed 
results from intervention studies in order to examine the effectiveness of anti-doping 
interventions by comparing the results in the experimental and control arms.  
By conducting a meta-analysis, one can examine whether real effects (i.e., effects that 
are unlikely to be due to chance) exist between two variables. Moreover, the magnitudes of 
such effects could be calculated using a standardized metric, which is useful for comparison 
purposes. Another goal when conducting meta-analyses is to test whether an effect size is 
moderated by certain variables (i.e., whether the effect size associated with the relationship 
between two variables varies at the different levels of the moderator variable). Testing for 
moderators is important because researchers can identify whether certain effects, such as the 
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influence of social norms on doping intentions, need to be dealt with differently in various 
groups (e.g., males versus females) or in certain contexts (e.g., competitive athletes versus 
gym users). Similarly, such moderator analysis could allow researchers to explore whether 
doping interventions are effective across populations and settings. 
 
Method 
Literature Search 
We conducted a literature search to identify studies that could be included in our analyses. 
We searched PsycINFO, PsycARTICLES, PubMed, Google Scholar, and Medline. 
Combinations of keywords specifying the subject (e.g., doping, performance enhancing drugs) 
and the context of interest (e.g., sport, exercise, and training) were used when performing the 
database searches (the list of variables used for the database search is shown in Appendix A). 
We also searched the WADA website for reports of previous studies funded by the agency. 
The reference lists of included articles were scanned for relevant documents that were not 
retrieved from the database searches. To locate and retrieve information from any 
unpublished datasets, we posted messages on electronic mailing lists (e.g., SPORTPSY) 
reaching out to social science researchers. Authors with a background in doping research 
were also invited via email requests to contact us if they had any unpublished information 
that was relevant to our study.  
Inclusion and Exclusion Criteria 
Studies that measured doping behaviors and doping intentions were included. Studies that 
measured one of these constructs and at least one other demographic (e.g., age, sex), personal 
psychological (e.g., attitudes, morality), or social-contextual (e.g., participation in team sport, 
motivational climate) variable were also included. When only the relation between scores 
reported by different individuals (e.g., association between coach and athlete ratings) was 
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reported, the corresponding study was excluded. 
Included Studies 
Using the above criteria, we identified 104 independent datasets. We contacted authors of the 
publications when information required for our meta-analysis was not available in their 
manuscripts. Forty one datasets were excluded because the corresponding authors either did 
not reply or were unable to provide any information that could be included in our analyses. 
Consequently, our final analyses included 63 independent datasets (see Appendix B). The 
majority of included studies were published journal articles (number of studies, k = 46). 
Other sources included online datasets (k = 11), theses/dissertations (k = 3), unpublished 
manuscripts/datasets (k = 2), and reports retrieved from the WADA website (k = 1). Most of 
the included studies were cross-sectional (k = 55). Far fewer studies used 
longitudinal/prospective (k = 4) or experimental designs (k = 4). 
Recording of Study Information 
Properties of the included studies or their participants were coded to allow moderator 
analyses to be conducted. We coded for the type of publication (e.g., published journal article, 
student thesis, manuscript under review), study design (e.g., cross-sectional, 
longitudinal/prospective, experimental), background of participants (e.g., competitive athletes, 
gym users, students), type of sport participants engaged in (e.g., team, individual), and age 
group of participants (e.g., adolescent, adults). The effect sizes between measured variables 
and self-reported doping behaviors/intentions were recorded. Effect sizes recorded were odds 
ratios (between dichotomous variables and doping behaviors), zero-order Pearson 
correlations (when one or both variables were ordinal or continuous), and Cohen’s d (for 
intervention versus control group comparisons). Cronbach's alphas of the measured 
constructs were also recorded to correct for measurement error in the meta-analyzed effect 
sizes (Hunter & Schmidt, 2004).  
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Assessment of Quality of Potential Biases of Included Studies 
To ensure study quality would not lead to biases in results, the quality of included studies was 
assessed (Higgins, Altman, & Sterne, 2011). The assessment tool developed by Higgins et al. 
(2011) was adopted in this study. However, as this tool was designed for studies using an 
experimental design only, we created other criteria (see Appendix C) for cross-sectional (e.g., 
whether valid measures were used) and longitudinal/prospective studies (e.g., whether 
dropout from the study was random). For each criterion, included studies were rated as 
having “low risk” or “high risk” of bias. A study would be deemed to have low risk of bias if 
it was rated as having “low risk” for all assessed criteria. The remaining studies (i.e., those 
with one or more criteria being considered as indicating “high risk”) were deemed as having 
potential risk of biases. 
To determine whether the assessment criteria were appropriate, two researchers rated 
the study quality of three studies (one cross-sectional, one longitudinal/prospective, and one 
experimental) individually. The assessment ratings were compared; out of all the ratings 
given for each of the three studies, only one was different, and this disagreement was 
resolved after a discussion. The rationales for giving the ratings for each subcategory were 
also discussed between the two raters to ensure that ratings were given based on similar 
evidence or reasons. The assessments of all other studies included in the meta-analyses were 
then conducted by one of the two researchers.  
Meta-Analytical Procedures 
The random effect methods proposed by Shadish and Haddock (1994) were used to meta-
analyze odds ratios (OR). The procedures suggested by Hunter and Schmidt (2004), which 
also adopt a random effect model, were used for Pearson correlations and Cohen’s d. The 
population effect size (OR, correlation [ρ], or standardized difference [δ], respectively) was 
calculated for each meta-analyzed relation, adjusting for sampling error (by taking into 
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account the sample size). When computing effect sizes, attenuation due to measurement error 
was corrected using Cronbach’s alphas. As Cronbach’s alphas were not available for all 
recorded effect sizes, the artifact distribution meta-analytical procedures (Hunter & Schmidt, 
2004) were employed. Further, 95% confidence intervals (95% CI) were generated for all 
meta-analyzed effect sizes. If the 95% CI of an effect size did not encompass the point 
estimate representing a null effect (i.e., 1 for OR, 0 for ρ and δ), the effect was considered to 
be real. When a real effect was found, the magnitude of the meta-analyzed effect sizes was 
labeled using the criteria suggested by previous researchers (Chen, Cohen, & Chen, 2010; 
Cohen, 1977). Essentially, an OR with a value between 1.68 to 3.47 was considered small, 
3.47 to 6.71 medium, and above 6.71 large (the reciprocals of these cut-off values were used 
when OR < 1). The cut-off values used to label small, medium, and large correlations 
were .1, .3, and, .5, respectively, and for standardized differences, we used values of 0.2, 0.5, 
and 0.8, respectively. 
To address the issue of possible publication bias in the literature (Rosenthal, 1979), 
we calculated the “fail-safe numbers” (FSNs) when small to medium, medium, or large 
effects were found. Essentially, a FSN represents the number of studies with null findings 
which, if included in the meta-analysis, would reduce the effect to a small size (i.e., 1.68 for 
OR, .1 for correlation, and 0.2 for standardized differences). The formula provided by Hunter 
and Schmidt (2004) was used to derive the FSNs for the meta-analyzed effect sizes. If the 
FSN corresponding to an effect size was large, it is considered unlikely that the effects found 
are due publication bias. 
To test for heterogeneity in the obtained effect sizes from odd ratios, the Q statistic 
(Shadish & Haddock, 1994) was used. A significant Q suggests that the included effect sizes 
are heterogeneous. For meta-analyses involving Pearson correlations or Cohen’s d, the 75% 
rule, proposed by Hunter and Schmidt (2004), was also used. Hunter and Schmidt suggested 
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that when more than 75% of the variance is attributed to sampling and measurement errors, it 
is likely that the included effect sizes are homogeneous. When either or both tests suggested a 
particular effect size to be heterogeneous (e.g., moral disengagement predicting doping 
intention), moderator analysis was conducted. In essence, separate sub-group effect sizes 
were calculated for each level of the potential moderator (e.g., separate effect sizes for the 
moral disengagement-doping intention relationship were calculated for different types of 
study design). A variable was considered to be moderating the size of an effect if the 95% CIs 
of any two sub-group effect sizes did not overlap (Hwang & Schmidt, 2011). The potential 
moderators we tested in this study were: sex of participants (males versus females), 
publication status (published [k = 46] versus unpublished [k = 17]), study design (cross-
sectional [k = 55] versus longitudinal/prospective [k = 4] versus experimental [k =4]), 
background of participants (competitive athletes [k = 16] versus gym users [k = 12] versus 
students [k = 35]), type of sport they participated (team sports [k = 4] versus individual sports 
[k = 11] versus a mixture of both [k = 21]), age group of participants (adults [k = 22] versus 
adolescents [k = 29] versus a mixture of both [k = 10]), and study quality (studies with low 
risk of bias [k = 55] versus studies with potential risk of bias [k = 8]). 
Path Analysis 
Using our meta-analyzed effect sizes, we conducted a path analysis of a model based on the 
Theory of Planned Behavior (Ajzen, 1991). Path analysis and meta-analysis can complement 
each other (Viswesvaran & Ones, 1995). Path analysis can capture simultaneous 
interdependencies between several variables after the meta-analysis has removed sampling 
and measurement errors. 
Results 
The results of all meta-analyzed effect sizes are presented in Table 1. As a meta-analysis 
could not be conducted with information from one study only, effect sizes from a single study 
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are shown in the tables but will not be interpreted further. When moderator effects were 
found (i.e., sub-group effect sizes had non-overlapping 95% CIs), the sub-group effect sizes 
are presented in Table 2.  
Meta-Analyzed Effect Sizes Comparing Intervention and Control Groups 
With respect to doping behaviors, we compared the differences in numbers of new reported 
cases of doping between the intervention and control groups over a season/one school year. 
We found that the interventions did not show a real effect in terms of reducing doping 
behaviors (OR = 0.76, 95% CI [0.27, 2.17]; OR < 1 indicates there were fewer reports of new 
doping behaviors in intervention groups). In terms of doping intentions, standardized 
difference scores between intervention and control groups were meta-analyzed. Over the 
same period of time, the interventions showed a very small reduction in doping intentions (δ 
= ˗0.12, 95% CI [˗0.13, -0.11]). Nonetheless, few studies (k = 3 and 2 for behaviors and 
intention, respectively) were included in these analyses, and therefore the results should be 
interpreted with caution.  
Effect Sizes of Demographic and Social-Contextual Variables Predicting Doping 
Behaviors or Doping Intentions 
A variety of demographic and social-contextual variables were examined in conjunction with 
doping behaviors or intentions in the included pool of studies. In terms of demographic 
variables, we found that males reported more doping behaviors than females (OR = 2.72, 
95% CI [2.16, 3.42]). We also found that doping behaviors were more prevalent in people 
who had friends that doped, compared to those who did not (OR = 6.40, 95% CI [3.46, 
11.84]). The use of legal supplements was related to more doping behaviors (OR = 8.24, 95% 
CI [5.07, 13.39]) and higher levels of doping intentions (ρ = .36, 95% CI [.20, .52]). Age was 
also found to be related to doping intentions (ρ = .05, 95% CI [.02, .09]). However, the size 
of this effect is very small.  
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In terms of moderator analyses, we found that the background of participants 
moderated the effect between sex and doping behaviors. Specifically, we found that this 
effect was stronger for gym users (OR = 7.77, 95% CI [5.31, 11.37]) than competitive 
athletes (OR = 2.17, 95% CI [1.16, 4.08]) and students (OR = 2.48, 95% CI [2.04, 3.00]). For 
the relation between age and doping behaviors, a very small negative effect was found in 
female (ρ = ˗.03, 95% CI [˗.05, ˗.02]), but not in male participants (ρ = .00, 95% CI 
[˗.01, .02]). Another moderator of the association between age and doping behaviors was the 
background of participants. Specifically, we found a very small effect between these 
variables in gym users (ρ = .09, 95% CI [.01, .17]), but not in students (ρ = ˗.01, 95% CI 
[˗.02, .003]) as the 95% CIs did not overlap. Further, studies with low risks of bias found a 
very small negative effect of age on doping behaviors (ρ = -.01, 95% CI [-.02, -.001]), but 
those with potential risk of bias reported a small positive effect (ρ = .14, 95% CI [.07, .21]). 
We also found that study design was a moderator of the age – doping intentions relation. 
Although a very small effect was found in both cross-sectional studies (ρ = .07, 95% CI 
[.04, .11]) and longitudinal/prospective studies (ρ = .00, 95% CI [.002, .004]), their 
corresponding 95% CIs did not overlap indicating that these effect sizes were not equivalent. 
Effect Sizes of Personal Psychological Variables Predicting Doping Behaviors/Intentions 
Some of the effect sizes of personal psychological variables predicting doping behaviors and 
intentions were based on a very small number of studies. Consequently, moderator analyses 
could not be conducted because when these effect sizes were broken down to moderator 
subgroups, there was insufficient number of studies for all subgroups to allow meaningful 
comparisons. To allow more meaningful comparisons across different levels of moderators, 
two more stages of analyses were conducted, after the initial stage that calculated an effect 
size for each psychological variable. In stage two, we collapsed the effect sizes of variables 
that are conceptually similar (e.g., self-efficacy to refrain from doping and perceived 
P a g e  | 13 
 
behavioral control; see Table 1 for details regarding how variables were combined) with 
appropriate reversing (e.g., moral disengagement was reversed when combining effect sizes 
of morality variables). If conceptually similar constructs were measured in the same study, 
the weighted averages of the coefficients of interest were used to form a single effect size 
from this study for the meta-analysis. For brevity reasons, we report below the findings from 
Stage 2 and 3 only, but the results from all stages are shown in Table 1. 
With respect to doping behaviors, we found real positive effects from intentions (ρ 
= .38, 95% CI [.21, .55]), attitudes (ρ = .17, 95% CI [.04, .29]), norms (ρ = .36, 95% CI 
[.27, .45]), and amotivation (ρ = .17, 95% CI [.07, .26]). The sizes of these effects were small 
to medium. Real negative effects to doping behaviors were also found from self-efficacy to 
refrain from doping (ρ = ˗.12, 95% CI [˗.21, ˗.02]), morality (ρ = ˗.21, 95% CI [˗.32, ˗.10]), 
autonomous motivation (ρ = ˗.06, 95% CI [˗.09, ˗.03]), and task achievement goal orientation 
(ρ = ˗.09, 95% CI [˗.17, ˗.01]). The effects of the latter two variables though were very small. 
The FSN for the effect between self-efficacy to refrain from doping and doping behaviors 
was 1 (k = 5), suggesting that only one study with null findings was need to reduce this effect 
to what is considered a small effect (i.e., reduce it from ρ = ˗.12 to ρ = ˗.10).  
In terms of predicting doping intentions, large positive effects were found for attitudes 
(ρ = .52, 95% CI [.44, .60]) and norms (ρ = .53, 95% CI [.43, .63]). Small effects were found 
from dissatisfaction with appearance/body image (ρ = .20, 95% CI [.12, .29]), amotivation (ρ 
= .24, 95% CI [.20, .27]), and ego achievement goal orientation (ρ = .14, 95% CI [.09, .20]). 
However, the effect size between doping intentions and ego achievement goal orientation has 
a FSN of 2 (k = 4). Small to moderate negative effects were also found from self-efficacy to 
refrain from doping (ρ = ˗.27, 95% CI [˗.41, ˗.14]) and morality (ρ = ˗.31, 95% CI [˗.47, 
˗.16]). A real effect was also found from task achievement goal orientation (ρ = ˗.08, 95% CI 
[˗.14, ˗.02]). Nonetheless, the size of this latter effect is very small. 
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For the third stage of our analyses, variables were categorized as either a facilitator or 
inhibitor of doping intention or behaviors. A variable was categorized as a facilitator if a real 
positive effect with doping intention/behaviors was found in the previous stages. In contrast, 
variables with real negative effects were considered as inhibitors. Based on this 
categorization, we collapsed the effect sizes associated with all facilitators and inhibitors and 
conducted meta-analyses and moderator analyses using the combined effect sizes. The 
variables included in these analyses are shown in Table 1. Forrest plots representing the third 
stage of meta-analyses are presented in Appendix D.  
We found that the sizes of effects for the facilitators (ρ = .20, 95% CI [.08, .32]) and 
inhibitors (ρ = ˗.13, 95% CI [˗.19, ˗.07]) variables were small. The FSN for the effect 
between doping behaviors and inhibitors was also small (FSN = 4, k = 11), suggesting that a 
relatively small number of studies (i.e., 4) with null findings would bring the meta-analyzed 
effect to a very small value. With respect to doping intentions, we found a medium effect 
from facilitators (ρ = .44, 95% CI [.36, .51]) and inhibitors (ρ = ˗.28, 95% CI [˗.39, ˗.17]). 
In this third stage of analysis we also found some moderation effects. For the 
facilitators – doping behaviors relation, a medium effect size was found when only studies 
with low risk of bias were included (ρ = .31, 95% CI [.21, .41]). However, a small negative 
effect was found in studies that were rated to have potential risks of bias (ρ = -.10, 95% CI [-
.13, -.06]). We also found that the relation between facilitators and doping intentions was 
moderated by publication status and study design. Specifically, we found that the effects in 
published datasets (ρ = .49, 95% CI [.40, .59]) were stronger than those found in unpublished 
datasets (ρ = .31, 95% CI [.24, .39]). Nonetheless, the size of both effects was medium. In 
terms of study design, we found a medium effect for cross-sectional studies (ρ = .40, 95% CI 
[.31, .48]), but a large effect for longitudinal/perspective studies (ρ = .56, 95% CI [.52, .61]). 
Study design also moderated the inhibitors-doping intentions relation. A small effect was 
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found in cross-sectional studies (ρ = ˗.21, 95% CI [˗.33, ˗.10]), but the magnitude of the 
effect was stronger in longitudinal/prospective studies (ρ = ˗.44, 95% CI [˗.45, ˗.43]). Finally, 
we found that the effect size between inhibitors and doping intentions was small in 
competitive athletes (ρ = ˗.16, 95% CI [˗.29, ˗.02]), but large in gym users (ρ = ˗.62, 95% CI 
[˗.85, ˗.40]). 
Path Analyses of a Theory of Planned Behavior Model 
The Theory of Planned Behavior (TPB; Ajzen, 1991; Fishbein & Cappella, 2006) was the 
most utilized theoretical framework within the pool of included studies. Thus, in order to 
examine the inter-relation between all TPB constructs and doping behaviors and intentions, 
we conducted path analyses using meta-analyzed effect sizes from the second stage of our 
analyses. Path analyses were conducted using Mplus (Muthén & Muthén, 2008). Following 
recommendations by Viswesvaran and Ones (1995), the harmonic mean of the sample sizes 
underpinning the corresponding effect sizes of the correlation matrix was used as the total 
sample size (n = 5,046) for the tested models. Based on the model proposed by Fishbein and 
Cappella (2006), we tested an initial model with attitudes, norms, and self-efficacy to refrain 
from doping predicting intentions to dope, which in turn predicted doping behaviors. This 
model did not fit well (Hu & Bentler, 1999): 2(3) = 288.98, p < .001, Comparative Fit Index 
(CFI) = .92, Root Mean Square Error of Estimation (RMSEA) = .14, Standardized Root 
Mean Square Residual (SRMR) = .04. 
We tested three other plausible alternative models by freeing direct paths from 
attitudes, norms, and self-efficacy to refrain from doping (only one of these paths was freed 
in each alternative model) to doping behaviors. A plausible model was accepted if the 
improvement in CFI was larger than .01 compared to the initial model (Cheung & Rensvold, 
2002). The alternative models with direct paths from attitudes or self-efficacy to refrain from 
doping to behaviors did not meet this criterion and were rejected. However, the model with a 
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direct path from norms to doping behaviors (see Figure 1) was accepted (change in CFI 
= .060). This final model had a significant 2, but other fit indices suggested a good model fit: 
2 (2) = 78.35, p < .001, CFI = .98, RMSEA = .09, SRMR = .02. In this model, the direction 
of paths from attitudes (β = .31), norms (β = .34), and self-efficacy to refrain from doping (β 
= ˗.14) to doping intentions were in the expected direction (all path p < .001). Paths from 
norms (β = .22, p < .001) and intention (β = .26, p < .001) to doping behaviors were also 
positive. Indirect effects from attitudes (β = .12) and self-efficacy to refrain from doping (β = 
˗.06) were also significant at p < .001. 
 
 
 
 
Figure 1. Path diagram of a theory of planned behavior model using meta-analyzed 
correlations (n = 5,046). All paths significant at p < .001. 
 
P a g e  | 17 
 
Discussion 
The primary aim of the current study was to quantitatively combine research findings in the 
extant literature in an effort to identify key factors that are related to doping intentions and 
doping behaviors. This study provides the first meta-analytic accumulation of psychological 
studies examining predictors of doping intentions and behaviors.  
The strongest effects of psychological variables on doping behaviors, including 
intentions to dope and perceived norms, were only medium in size. These findings 
corroborate Petróczi and Aidman’s (2008) argument that doping behaviors represent a 
complex interplay of multiple factors, and hence may not be explained by a few variables 
alone. Given that intentions to dope were found to be one of the strongest predictors of 
doping behaviors, we deemed important to also explore the factors predicting this variable. In 
general, our results indicated that the predictor variables used in the literature predicted 
stronger doping intentions compared to actual doping use. 
We first evaluated the effectiveness of existing randomized control trials and we were 
only able to include four experimental studies in our analyses. This is because the required 
effect sizes were not available in some of the published papers (nor were made available to us 
despite our requests), and therefore some such studies had to be excluded. Consequently, our 
results with respect to trial effectiveness should be interpreted with caution. Still, the four 
studies presented data from the evaluations of two long standing North American prevention 
programs, namely the: Adolescents Training and Learning to Avoid Steroids (ATLAS; 
Goldberg & Elliot, 2005; Goldberg et al., 1996; Goldberg et al., 2000) and Athletes Targeting 
Healthy Exercise and Nutrition Alternatives (ATHENA; Elliot et al., 2008; Goldberg & Elliot, 
2005) programs. Targeted at adolescents and commercially sold to schools in the US for use 
with sports teams, these programs are gender-specific and student-led. We found that the 
trials included in our analyses showed a very small reduction in doping intentions but no 
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changes in doping behavior. This might be attributed to the content of the ATLAS and 
ATHENA interventions. Both tackle doping alongside other behaviours, including healthy 
eating and training regimes. Perhaps the lack of a clear focus on doping explains the small 
effect on intentions and behaviour. For instance, ATHENA is largely focused on information 
and activities about healthy and disordered eating, drug use (i.e., alcohol, tobacco, marijuana 
and anabolic steroids), monitoring nutritional intake, and improving psychological factors, 
such as depression and mood (Elliot et al., 2004, 2008; Ranby et al., 2009). Hence, both these 
interventions aim to influence athletes’/students’ overall health-related behaviors and are not 
focused specifically on doping use behaviors. Further, it is possible that the small effects 
found in these interventions reflect floor effects, in that participants had low initial intentions 
to dope, and therefore, there was not much room for a reduction in their doping-related 
intentions and behaviors. For example, in Goldberg et al. (1996) study, intention to use 
steroids at pretest was 5.7 and 6.3 in the experimental and control group, respectively (1-7 
scale with 7 being no intent to use).  
Thus far, the programs have not been adopted by national and international anti-
doping agencies. One possible reason for this is the time commitment involved in delivering 
their curriculum in order to ensure program fidelity. The sheer cost of rigorous evaluation 
could explain the relatively small number of intervention studies. Consequently the ATLAS 
and ATHENA programs remain the only programs where prolonged monitoring and 
evaluation has been undertaken and findings widely disseminated.  
We also included in our meta-analysis effect sizes from non-experimental studies. We 
found that factors such as being male, using legal supplements, knowing friend(s) who dope, 
having a positive attitude towards doping, perceiving doping to be normal, having a lower 
body image, lacking autonomous motivation in exercise or sport, and having an ego goal 
orientation may facilitate doping intentions and behaviors. In contract, having higher self-
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efficacy to refrain from doping, having higher moral standards, having a task goal orientation, 
and anticipating feelings of regret were found to be inhibitors of doping. However, most of 
the effects were small to medium in size.  
Use of legal supplements was the only variable which had a large effect on doping 
behaviors (k = 6). This suggests that users of legal supplements are at a much higher risk of 
using illegal drugs. This finding is notable when one consider the widespread use of legal 
supplements across all levels of sport (Burns, Schiller, Merrick, & Wolf, 2004; Hoffman et 
al., 2008; Maughan, Depiesse, & Geyer, 2007; Tscholl, Alonso, Dollé, Junge, & Dvorak, 
2010).  
Backhouse and colleagues (2011) suggested that a gradual increase in the use of 
nutritional supplements can serve as a gateway to doping use mainly because it familiarizes 
athletes with chemically-assisted performance enhancement. In a sample of competitive 
athletes, they found that doping use was three-and-a-half times more prevalent in nutritional 
supplement (NS) users compared with nonusers. This finding was accompanied by significant 
differences in doping attitudes and beliefs between NS users and nonusers. In a similar vein, 
Tsorbatzoudis, Barkoukis, and Lazuras (2013) indicated that NS users are two to three times 
more likely to report doping use and they also displayed biased normative beliefs related to 
doping use (i.e., they perceived doping as more prevalent in fellow athletes and socially 
approved). Nevertheless, causality remains to be determined as the gateway hypothesis is 
based largely on cross-sectional data. NS use is seen as an alternative to doping in the context 
of chemically-assisted performance enhancement. However, athletes should operate with 
caution when using NS because a number of risks are present. The supplement industry is 
largely unregulated and contamination with substances that could lead to a positive dope test 
has been repeatedly reported (e.g., Geyer et al., 2008). Therefore, targeted education is 
necessary to ensure athletes are able to make an informed choice when assessing the need and 
P a g e  | 20 
 
the risk of using a NS. 
Notably, several of the psychological variables that may be related to doping 
behaviors were only measured in one study, and hence the results pertaining to these 
variables should be viewed with caution. Some of these constructs (e.g., religiousness, 
willingness to dope) showed a large effect with doping behaviors in their corresponding study. 
For example, Whitaker (2013) applied the Prototype Willingness Model (Gibbons, Gerrard, 
Blanton, & Russell, 1998) to doping behaviors in an attempt to overcome the issue of the 
weak intention-behavior relationship. This model accounts for the fact that social settings, 
such as those found on a sports team, can afford opportunities to engage in risky behaviors 
that might overwhelm athletes’ good intentions. The results of Whitaker (2013) show that 
willingness to dope was significantly predicted by athletes’ attitudes towards doping, PED 
user prototype perceptions and subjective norms (perceptions of significant others’ approval 
of doping). Descriptive norms (perceived PES use by other in their sport) were also a 
significant predictor of county, national and international level athletes’ willingness to dope. 
Further research exploring the utility of this model in the context of doping in sport is needed.  
In this study we also examined whether other factors, such as participants’ 
demographic variables or study quality, may moderate the effect sizes found. Although some 
of the effects varied in size across different levels of moderators, in general, the direction of 
the effects remained unchanged. However, we found that the effect sizes from some studies 
deemed as having potential biases may alter the directions of the effect in an unexpected way 
(e.g., a negative effect between facilitators and doping behaviors). These findings, therefore, 
emphasize the importance of eliminating all possible sources of biases when conducting 
primary research in this field as potential biases may lead to dubious results.  
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Path Analysis 
By using the meta-analyzed effect sizes in path analysis, we also tested a path model based 
on the TPB. We found that the prediction paths from attitudes, perceived norms, and self-
efficacy to refrain from doping to doping intentions were in the expected directions. Further, 
a positive path from doping intentions to doping behaviors was found. By comparing 
alternative nested models, we found that perceived norms may have a direct effect on doping 
behaviors. These results are slightly unexpected because in Ajzen’s (1991) conceptualization 
of the TPB model, perceived behavioral control (later combined with self-efficacy; see 
Fishbein & Cappella, 2006) had a direct effect on behaviors, but not perceived norms. This 
finding demonstrates the important role social environment can play in an athlete’s decision 
to use prohibited substances. Normative influences to engage in doping can range from mere 
peer pressure and perceived social acceptability of doping by teammates, to pressures 
associated with results and enhanced performance. Hence, the influence of the athlete’s 
‘sportsnet’ (e.g., coach and teammates) and perceptions on the prevalence of doping use 
among other athletes seem to be important factors determining the decision making process 
related to doping use. The findings of this meta-analysis underline the importance of 
addressing the context of the social environment through a multifaceted education program. 
In essence, interventions which target athletes’ social norm perceptions, images of a doper 
and reduce the vulnerability to doping through the development of self-regulation skills (i.e., 
resilience, self-control and problem solving) should be designed and evaluated. Moreover, 
influential others such as coaches, teachers and parents need to become part of this 
multifaceted approach to doping prevention. To facilitate this engagement the intervention 
content should reflect the needs and possible influence of these groups (Backhouse, Patterson, 
& McKenna, 2012).  
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Limitations 
A meta-analysis can be only as good as the studies included in it. The most important 
limitation of this work is that many meta-analyzed effect sizes were based on a small number 
of studies. This is because the studies conducted in this area have been very broad, perhaps 
too broad, in terms of identifying demographic, personal, and situational predictors of doping 
intentions and behavior. Nevertheless, this review represents an initial effort to quantify the 
psychosocial variables that are most strongly related to doping behaviors or intentions to 
engage in such behaviors. Also, the current conclusions assume that self-reported behaviors 
are accurate reflections of people’s actions (all included studies used self-reports to measure 
doping behavior). Further, most of the meta-analyzed effect sizes between predictors of 
doping with doping intentions and behaviors were derived from correlational studies; more 
intervention studies in this area are needed. As a consequence, our results cannot establish 
causal relations. For example, a large effect size between perceived norms and intentions may 
also suggest people having stronger intentions to dope would perceive more people to be 
doping (Petroczi, Mazanov, Nepusz, Backhouse, & Naughton, 2008). Similarly, people may 
report having more positive attitudes towards doping because they intend to use illegal 
substances. Experimental studies are required to examine the causal relations between these 
variables. Another limitation was that we were unable to test some potentially important 
moderator effects. For example, in studies that reported the numbers or percentages of 
participants using legal substance, these were reported for the total sample and not by 
subgroups. Therefore, comparing effect sizes different levels of moderators was not possible, 
unless authors were willing to provide us with access to their raw data.  
 
Practical Conclusions 
To conclude, we discuss some practical implications of our results. From the individual 
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viewpoint, athletes should be cautious in that estimates of doping use among their fellow 
athletes and elite athletes are often exaggerated. This is very important as descriptive norms 
emerged as an important predictor of intentions and actual doping use. Future research and 
preventive guidelines regarding the social environment should focus on a) the role of coaches 
and their coaching style, and b) peers and the pressure they can exert on the athlete to decide 
to use doping substances. Importantly, future prevention interventions should improve 
athletes’ self-efficacy in resisting pressures imposed by coaches or peers, and also their 
ability to resist temptations (i.e., outcomes of success such as money, fame etc.) which might 
resort in doping use. In addition, we showed that high moral standards are an important 
protective factor, especially in young athletes. Thus, aspects of ethical decision making 
should be incorporated in interventions designed to tackle doping use. Finally, doping-related 
interventions should inform athletes on the risks and appropriate use of nutritional 
supplements. It is important that athletes perceive nutritional supplements as an alternative to 
doping use and not as a getaway. Moreover, given the number of claims of inadvertent 
doping through the use of nutritional supplements at a global level, regulation of the industry 
and efficacy trials (assessing the performance benefits and health risks associated with use), 
is required in order to enable athletes to make an informed choice. 
 In sum, we found that doping behaviors may be explained by a combination of 
demographic, social-contextual, and psychological variables. Therefore, the punitive 
detection-deterrence approach may not be effective in reducing the prevalence of doping 
behaviors. If a shift towards primary prevention is to take place, researchers, policy makers, 
and practitioners need to discover, apply, and evaluate educational curricula that focus on the 
social-contextual and psychological determinants of these behaviors. From our results we 
recommend placing greater emphasis on modifying norm-based doping perceptions and 
creating optimal motivational coaching and peer environments. Further, effective prevention 
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interventions to tackle doping use should target athletes’ perceptions, cognitions and moral 
stance, empowering them to resist temptations and choose appropriate ways to enhance 
performance. 
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Table 1 
Results of Meta-Analyses and Homogeneity Tests Predicting Doping Behavior and Doping Intentions 
 k n Effect Size 95% CI FSN Q % error variance 
Stage one analyses        
Comparisons of intervention and control 
groups (Scores of intervention groups minus 
those of control groups) 
       
Behavior (pre- to post-season/school year) 3 3,718 0.76a [0.27, 2.17] — 3.38 — 
Behavior (1 year post-intervention) 1 1,291 0.36a [0.12, 1.10] — — —
Intention (pre- to post-season/school year) 2 3,333 -0.12b [-0.13, -0.11] — 0.03 100.0% 
Intention (1 year post-intervention) 1 1,291 -0.13b [-0.24, -0.02] — — —
  
Association with doping behaviors        
Demographic variables        
Sex (males vs. females) 43 247,590 2.72a [2.16, 3.42] 40 266.37* — 
Age 34 182,435 -.01c [-.02, .003] — 185.72* 19.2% 
Legal supplement use 6 4,568 8.24a [5.07, 13.39] 19 12.57* —
Know friend who is doping 5 2,224 6.40a [3.46, 11.84] 13 7.94 —
        
Social-contextual environment        
Team sports participation (versus other types) 5 3,309 0.96a [0.67, 1.38] — 2.04 — 
Task-involving motivational climate 1 374 .07c [-.03, .17] — — —
Ego motivational climate 1 374 -.08c [-.18, .02] — — —
        
Theory of Planned Behavior variables        
Intention1 10 5,544 .38c [.21, .55] 29 812.44* 2.5% 
Attitudes 13 7,992 .12c [-.06, .30] — 912.51* 2.1% 
Knowledge of doping 1 2,285 .08c [.04, .12] — — —
Perceived benefits of doping 3 1,551 .27c [.16, .37] 5 11.26* 27.0% 
Perceived negative outcomes of doping 1 167 -.08c [-.23, .07] — — —
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 k n Effect Size 95% CI FSN Q % error variance 
Beliefs regarding whether doping should be 
legalized 
1 205 .52c [.42, .62] 5 — —
Subjective norms 8 4,084 .36c [.23, .48] 21 160.17* 6.4% 
Descriptive norms 3 1,233 .49c [.27, .70] 12 43.85* 5.8%
Moral norms 1 640 .40c [.33, .46] 3 — —
Perceived behavioral control 5 3,073 -.01c [-.07, .05] — 9.86* 51.3% 
Self-efficacy to refrain from doping 1 762 -.22c [-.29, -.16] 2 — —
Situational temptations 2 949 .47c [.42, .52] 8 1.53 100.0% 
        
Other personal psychological variables        
Sportspersonship 4 3,159 -.15c [-.21, -.09] 2 10.78* 37.2% 
Moral disengagement 3 2,358 .30c [.10, .49] 6 67.08* 4.3% 
Dissatisfaction with appearance or body 
image1 
1 203 .15c [.02, .29] 1 — —
Autonomous motivation2 6 3,779 -.06c [-.09, -.03] — 4.96 100.0% 
Controlled motivation 6 3,777 .02c [-.02, .06] — 6.96 86.9% 
Amotivation1 5 2,574 .17c [.07, .26] 4 24.32* 20.9% 
Task achievement goal orientation2 5 2,543 -.09c [-.17, -.01] — 17.57* 31.0% 
Ego achievement goal orientation 5 2,536 .04c [-.02, .11] — 10.72* 47.3% 
Global self-esteem 3 924 -.03c [-.07, .01] — 0.83 100.00% 
Perfectionism 2 463 -.10c [-.19, .001] — 2.00 98.8% 
Religiousness2 1 27 -.58c [-.84, -.32] 5 — —
Sport confidence 1 374 -.04c [-.15, .06] — — —
Anticipated regret2 1 641 -.13c [-.21, -.05] 1 — —
Threat of being caught 1 644 .04c [-.04, .12] — — —
Willingness to dope1 1 726 .54c [.49, .59] 5 — —
        
        
Association with doping intentions        
Demographic variables        
Sex (males versus females) 10 6,029 .07c [-.004, .15] — 95.39* 12.4%
Age 11 6,350 .05c [.02, .09] — 16.40 69.5% 
Legal supplement use 3 2,110 .36c [.20, .52] 8 47.09* 7.2% 
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 k n Effect Size 95% CI FSN Q % error variance 
Social-contextual environment        
Team sports participation (versus other types) 1 218 .08c [-.05, .21] — — —
        
Theory of Planned Behavior variables  
Attitudes 14 6,878 .55c [.47, .63] 63 188.38* 17.7% 
Knowledge of doping 1 144 .28c [.13, .43] 2 — —
Perceived benefits of doping 2 909 .17c [-.01, .35] — 16.01* 15.6% 
Perceived negative outcomes of doping 2 421 -.25c [-.33, -.16] 3 1.10 100.0% 
Beliefs regarding whether doping should be 
legalized 
1 203 .75c [.69, .81] 7 — —
Subjective norms 11 5,409 .55c [.44, .65] 49 146.13* 15.5% 
Descriptive norms 3 1,166 .21c [.10, .32] 4 8.95* 35.7% 
Moral norms 1 646 .65c [.60, .69] 6 — —
Social support to use illegal substances 1 144 .33c [.18, .48] 3 — —
Perceived behavioral control 8 4,456 -.08c [-.27, .10] — 448.79* 4.5% 
Self-efficacy to refrain from doping 4 2,102 -.55c [-.60, -.49] 18 6.51 100.0% 
Situational temptations 2 955 .68c [.43, .92] 12 45.80* 4.3% 
        
Personal psychological variables        
Sportspersonship 3 1,963 -.10c [-.22, .02] 1 19.42* 16.4% 
Moral disengagement 3 2,657 .48c [.40, .57] 12 12.57* 26.2% 
Dissatisfaction with appearance or body image 3 529 .19c [.03, .36] 3 9.03* 36.6% 
Drive for thinness 1 864 .16c [.10, .23] 1 — —
Drive for muscularity 1 864 .21c [.15, .28] 2 — —
Autonomous motivation 5 2,585 -.11c [-.23, .002] 1 40.80* 15.0%
Controlled motivation 5 2,583 .02c [-.04, .07] — 7.11 71.0% 
Amotivation1 5 2,581 .24c [.20, .27] 7 3.40 100.0% 
Task achievement goal orientation2 4 2,179 -.08c [-.14, -.02] — 5.38 75.8% 
Ego achievement goal orientation1 4 2,172 .14c [.09, .20] 2 4.88 83.2% 
Global self-esteem 1 191 -.03c [-.18, .11] — — —
Anticipated regret2 1 644 -.53 [-.59, -.48] 5 — —
Willingness to dope1 1 726 .16 [.06, .24] 1 — —
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 k n Effect Size 95% CI FSN Q % error variance 
Stage two analyses        
Association with doping behaviors        
Theory of Planned Behavior variables        
Attitudes1 
(also: knowledge of doping, perceived 
benefits of doping, perceived negative 
outcomes of doping [reversed], beliefs 
regarding whether doping should be 
legalized) 
16 8,227 .17c [.04, .29] 11 473.24* 4.6% 
Norms1 
(also: subjective norms, descriptive norms, 
moral norms) 
9 4,160 .36c [.27, .45] 24 82.15* 12.2% 
Self-efficacy to refrain from doping2 
(also: perceived behavioral control, 
situational temptations [reversed]) 
5 3,073 -.12c [-.21, -.02] 1 31.88* 17.5% 
        
Other personal psychological variables        
Morality2 
(also: sportspersonship, moral 
disengagement [reversed]) 
7 5,517 -.21c [-.32, -.10] 8 116.85* 6.7% 
        
Association with doping intentions        
Theory of Planned Behavior variables        
Attitudes1 
(also: knowledge of doping, perceived 
benefits of doping, perceived negative 
outcomes of doping [reversed], beliefs 
regarding whether doping should be 
legalized) 
14 6,829 .52c [.44, .60] 60 163.07* 15.8% 
Norms1 
(also: subjective norms, descriptive norms, 
moral norms, social support to use illegal 
substances) 
11 5,402 .53c [.43, .63] 48 135.51* 15.8% 
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 k n Effect Size 95% CI FSN Q % error variance 
Self-efficacy to refrain from doping2 
(also: perceived behavioral control, 
situational temptations [reversed]) 
9 4,601 -.27c [-.41, -.14] 16 182.17* 8.5% 
  
Personal psychological variables        
Morality2 
(also: sportspersonship, moral 
disengagement [reversed]) 
6 4,620 -.31c [-.47, -.16] 13 156.88* 4.8% 
Dissatisfaction with appearance or body 
image1 
(also: drive for thinness, drive for 
muscularity) 
4 1,393 .20c [.12, .29] 5 8.98* 48.5% 
        
Stage three analyses  
Association with doping behaviors        
Facilitators  17 9,297 .20c [.08, .32] 17 571.47* 3.9% 
Inhibitors 11 6,538 -.13c [-.19, -.07] 4 55.79* 23.4% 
        
Association with doping intentions        
Facilitators  15 7,875 .44c [.36, .51] 51 186.29* 14.3% 
Inhibitors 11 5,819 -.28c [-.39, -.17] 20 192.69* 9.6% 
        
Note. k = number of meta-analyzed studies; n = total number of participants; 95% CI = 95% confidence interval; FSN = fail-safe number, i.e., 
number of studies with null findings which, if included in the meta-analysis, would reduce the estimated effect to a very small size (if it is not 
already small); Q = Q statistic for test of homogeneity (shown when k>1); % error variance = percentage of variance accounted by sampling and 
measurement errors (shown when k>1). aOdds ratios; bCohen’s d; cCorrelation coefficient; * p < .05. 1Variable considered as a facilitator in stage 
three analyses; 2Variable considered as an inhibitor in stage three analyses.
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Table 2 
Differences in Effect Size Across Levels of Moderators 
Relationship [levels of moderator(s)] k n Size of effect Confidence interval Q % error variance 
Stage one analyses       
Sex – Doping behaviorsa       
Competitive athletes 12 4,834 2.17 [1.16, 4.08] 25.07* —
Gym users 4 2,692 7.77 [5.31, 11.37] 4.73 — 
Students 27 240,064 2.48 [2.04, 3.00] 187.24 — 
Age – Doping behaviorsb       
Males 33 89,680 .00 [-.01, .02] 115.42* 30.1% 
Females 28 91,488 -.03 [-.05, -.02] 100.25* 28.9% 
Cross-sectional studies 33 181,673 -.01 [-.02, .001] 144.11* 23.7%
Longitudinal studies 1 762 .22 [.15, .28] — — 
Gym users 5 713 .09 [.01, .17] 6.55 78.2% 
Students 18 176,377 -.01 [-.02, .003] 148.14* 12.8% 
Adolescents 15 168,668 -.01 [-.02, -.001] 77.03* 20.5% 
Mixed adults and adolescents 7 6,867 .07 [.02, .13] 40.38* 17.6% 
Studies with low risk of bias 31 179,895 -.01 [-.02, -.001] 119.09* 27.3% 
Studies with potential risk of bias 3 2,540 .14 [.07, .21] 9.29* 31.7% 
Intention – Doping behaviorsb       
Team sports participants 1 236 -.07 [-.20, .06] — — 
Mixed team and individual sports participants 7 3,946 .44 [.25, .63] 513.79* 2.7% 
Studies with low risk of bias 9 5,308 .40 [.22, .57] 723.22* 2.4% 
Studies with potential risk of bias 1 236 -.06 [-.19, .07] — — 
Attitudes – Doping behaviorsb       
Studies with low risk of bias 11 5,477 .29 [.16, .42] 289.03* 5.5% 
Studies with potential risk of bias 2 2,515 -.36 [-.48, -.23] 9.72* 19.0% 
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Relationship [levels of moderator(s)] k n Size of effect Confidence interval Q % error variance 
Perceived positive effects – Doping behaviorsb       
Adults 2 909 .34 [.16, .37] 0.79 100.0% 
Mixed adults and adolescents 1 642 .16 [.09, .24] — — 
Subjective norms – Doping behaviorsb 
Team sports participants 1 236 -.06 [-.19, .06] — — 
Mixed team and individual sports participants 6 2,896 .39 [.25, .54] 111.37* 6.9% 
Studies with low risk of bias 7 3,848 .38 [.26, .50] 117.52* 8.0% 
Studies with potential risk of bias 1 236 -.06 [-.19, .06] — — 
Descriptive norms – Doping behaviorsb       
Males 2 599 .64 [.61, .67] 0.46 100.0% 
Females 3 464 .26 [.15, .37] 5.17 72.6% 
Adults 2 938 .59 [.59, .60] 0.02 100.0% 
Adolescents 1 295 .15 [.04, .26] — — 
Perceived behavioural control – Doping 
behaviorsb 
      
Cross-sectional studies 4 2,311 -.05 [-.08, -.01] 2.23 100.0% 
Longitudinal studies 1 762 .09 [.02, .16] — — 
Moral disengagement – Doping behaviorsb       
Competitive athletes 1 644 .01 [-.06, .09] — — 
Students 2 1,714 .40 [.38, .42] 0.48 100.0% 
Amotivation – Doping behaviorsb       
Adults  1 410 -.07 [-.16, .03]   
Adolescents  1 304 .20 [.10, .31]   
Mixed adults and adolescents 3 1,860 .22 [.17, .26] 2.73 100.0% 
Task achievement goal orientation – Doping 
behaviorsb 
      
Competitive athletes 4 2,343 -.07 [-.13, -.004] 7.55 54.3% 
Students 1 200 -.32 [-.44, -.19] — — 
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Relationship [levels of moderator(s)] k n Size of effect Confidence interval Q % error variance 
Age – Doping intentionsb       
Cross-sectional studies 9 4,645 .07 [.04, .11] 11.11 84.1% 
Longitudinal studies 2 1,705 .003 [.002, .004] 0.00 100.0% 
Attitudes – Doping intentionsb 
Team sports participants 1 240 .73 [.67, .79] — — 
Mixed team and individual sports participants 8 4,015 .54 [.41, .66] 118.03* 14.3% 
Adults 4 1,567 .38 [.19, .56] 72.28* 12.0% 
Mixed adults and adolescents 5 2,195 .68 [.63, .73] 13.54* 100.0% 
Perceived benefits – Doping intentionsb       
Published datasets / Longitudinal studies 1 183 .43 [.31, .55] — — 
Unpublished datasets / Cross-sectional studies 1 726 .10 [.03, .17] — — 
Descriptive norms – Doping intentionsb       
Adolescents 1 296 .07 [-.04, .19] — — 
Mixed adults and adolescents 1 144 .40 [.26, .53] — — 
Perceived behavioural control – Doping 
intentionsb 
      
Competitive athletes 3 1,136 .11 [-.12, 35] 28.98* 11.3% 
Gym users 1 253 -.91 [-.93, -.89] — — 
Students 4 3,067 -.09 [-.22, .04] 31.65* 13.8% 
Individual sports participants 1 253 -.91 [-.93, -.89] — — 
Mixed team and individual sports participants 5 2,841 -.03 [-.19, .12] 54.26* 9.9% 
Studies with low risk of bias 7 4,274 -.10 [-.29, .09] 414.67* 4.5% 
Studies with potential risk of bias 1 182 .35 [.22, .47] — — 
Situational temptations – Doping intentionsb       
Adolescents 1 309 .42 [.33, .51] — — 
Mixed adults and adolescents 1 646 .80 [.77, .83] — — 
Sportspersonship – Doping intentionsb       
Published datasets 1 1,024 -.02 [-.08, .05] — — 
Unpublished datasets 2 939 -.20 [-.31, -.09] 4.72* 41.9% 
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Relationship [levels of moderator(s)] k n Size of effect Confidence interval Q % error variance 
Moral disengagement – Doping intentionsb       
Cross-sectional studies / Mixed adults and 
adolescents 
1 952 .37 [.31, .42] — — 
Longitudinal studies / Adolescents 2 1,705 .55 [.54, .56] 0.13 100.0%
Dissatisfaction with appearance – Doping 
intentionsb 
      
Competitive athletes 1 182 .39 [.26, .51] — — 
Students 1 203 .06 [-.08, .20] — — 
Adults 1 182 .39 [.26, .51] — — 
Mixed adults and adolescents 2 347 .09 [.04, .15] 0.38 100.0% 
Legal supplement use – Doping intentionsb       
Adolescents 2 1,158 .23 [.19, .27] 0.84 100.0% 
Mixed adults and adolescents 1 952 .51 [.47, .56] — — 
Autonomous motivation – Doping intentionsb       
Adults 1 410 -.41 [-.49, -.33] — — 
Adolescents 1 307 -.04 [-.15, .07] — — 
Mixed adults and adolescents 3 1,868 -.06 [-.11, -.02] 2.05 100.0% 
Controlled motivation – Doping intentionsb       
Competitive athletes 3 1,976 -.01 [-.06, .05] 3.21 94.4% 
Students 2 607 .10 [.09, .11] 0.02 100.0% 
       
Stage two analyses       
Attitudes (composite) – Doping behaviorsb       
Studies with low risk of bias 14 5,710 .28 [.18, .39] 224.58* 9.0% 
Studies with potential risk of bias 2 2,518 -.10 [-.12, -.08] 0.39 100.0% 
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Relationship [levels of moderator(s)] k n Size of effect Confidence interval Q % error variance 
Norms (composite) – Doping behaviorsb       
Published datasets 6 2,493 .29 [.17, .40] 49.21* 14.9% 
Unpublished datasets 3 1,667 .47 [.42, .52] 3.88 97.7% 
Team sports participants 1 236 .06 [-.07, .19] — —
Mixed team and individual sports participants 6 2,890 .39 [.27, .51] 58.69* 11.1% 
Adults  4 1,269 .50 [.43, .56] 6.11 67.2% 
Adolescents  3 1,299 .20 [.06, .35] 20.71* 17.5% 
Studies with low risk of bias 8 3,924 .38 [.29, .47] 62.25* 14.5% 
Studies with potential risk of bias 1 236 .06 [-.07, .19] — — 
Self-efficacy to refrain from doping 
(composite) – Doping behaviorsb 
      
Competitive athletes 2 949 -.28 [-.32, -.24] 0.69 100.0% 
Students 3 2,124 -.04 [-.09, -.002] 2.19 100.0% 
Morality (composite) – Doping behaviorsb       
Cross-sectional studies 6 4,755 -.18 [-.29, -.07] 91.34* 7.7% 
Longitudinal studies 1 762 -.39 [-.45, -.33] — — 
Competitive athletes 5 3,803 -.12 [-.19, -.06] 19.19* 26.3% 
Students 2 1,714 -.40 [-.42, -.38] 0.48 100.0% 
Attitudes (composite) – Doping intentionsb       
Team sports participants 1 240 .72 [.66, .78] — — 
Individual sports participants 2 397 .55 [.47, .63] 1.39 100.0% 
Mixed team and individual sports participants 8 3,966 .51 [.38, .64] 124.36* 11.4% 
Adults 4 1,518 .31 [.16, .45] 27.19* 18.8% 
Adolescents 5 3,116 .54 [.46, .63] 33.37* 39.0% 
Mixed adults and adolescents 5 2,195 .64 [.59, .69] 7.91 100.0% 
Norms (composite) – Doping intentionsb       
Team sports participants 1 241 .70 [.64, .76] — — 
Mixed team and individual sports participants 7 3,812 .49 [.36, .62] 106.12* 12.6% 
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Relationship [levels of moderator(s)] k n Size of effect Confidence interval Q % error variance 
Self-efficacy to refrain from doping 
(composite) – Doping intentionsb 
      
Competitive athletes 3 1,137 -.32 [-.36, -.29] 0.73 100.0% 
Gym users 2 397 -.64 [-.88, -.41] 12.05* 30.0%
Students 4 3,067 -.21 [-.40, -.02] 74.82* 6.5% 
Individual sports participants 2 397 -.64 [-.88, -.41] 12.05* 30.0% 
Mixed team and individual sports participants 5 2,842 -.34 [-.36, -.31] 1.61 100.0% 
       
Morality (composite) – Doping intentionsb       
Cross-sectional studies 4 2,915 -.19 [-.33, -.04] 54.70* 8.0% 
Longitudinal studies 2 1,705 -.55 [-.56, -.54] 0.13 100.0% 
Competitive athletes 3 1,963 -.10 [-.22, .02] 19.42* 16.4% 
Students 3 2,657 -.48 [-.57, -.40] 12.57* 26.2% 
       
Stage three analyses       
Facilitators – Doping behaviorsb       
Studies with low risk of bias 15 6,779 .31 [.21, .41] 268.17* 7.4% 
Studies with potential risk of bias 2 2,518 -.10 [-.13, -.06] 1.20 100.0% 
       
Inhibitors – Doping behaviorsb       
Cross-sectional studies 10 5,776 -.11 [-.17, -.06] 47.45* 25.9% 
Longitudinal studies 1 762 -.24 [-.31, -.17] — — 
Competitive athletes 6 4,186 -.09 [-.14, -.04] 11.77* 52.0% 
Gym users 1 27 -.65 [-.87, -.43] — — 
Students 4 2,325 -.19 [-.29, -.10] 18.09* 22.5% 
Individual sports participants 1 27 -.65 [-.87, -.43] — — 
Mixed team and individual sports participants 8 5,149 -.12 [-.17, -.06] 25.64* 32.6% 
Studies with low risk of bias 10 6,511 -.13 [-.18, -.07] 43.10* 24.3% 
Studies with potential risk of bias 1 27 -.65 [-.87, -.43] — — 
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Relationship [levels of moderator(s)] k n Size of effect Confidence interval Q % error variance 
Facilitators – Doping intentionsb       
Published datasets 9 5,411 .49 [.40, .59] 107.42* 16.2% 
Unpublished datasets 6 2,464 .31 [.24, .39] 16.08* 44.7% 
Cross-sectional studies 12 5,946 .40 [.31, .48] 155.31* 14.1%
Longitudinal studies 3 1,930 .56 [.52, .61] 3.15 100.0% 
Team sports participants 1 241 .70 [.64, .77] — — 
Mixed team and individual sports participants 9 5,012 .39 [.29, .49] 108.22* 13.7% 
       
Inhibitors – Doping intentionsb       
Cross-sectional studies 9 4,114 -.21 [-.33, -.10] 162.25* 10.7% 
Longitudinal studies 2 1,705 -.44 [-.45, -.43] 0.07 100.0% 
Competitive athletes 4 2,157 -.16 [-.29, -.02] 30.36* 15.0% 
Gym users 2 397 -.62 [-.85, -.40] 12.05* 26.7% 
       
Note. k = number of meta-analyzed studies; n = total number of participants; Q = Q statistic for test of homogeneity (shown when k>1).; % error 
variance = percentage of variance accounted by sampling and measurement errors (shown when k>1).. aOdds ratios; bCorrelation coefficient; * p 
< .05.  
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Appendix A 
Keywords Used for Database Search 
Keywords used: 
Doping, doping intention, steroid, medication, substance, stimulants, growth hormone, 
performance enhancement, performance enhancing drugs, amphetamine, blood transfusion, 
drug test, blood-booster 
In conjunction with: 
Psychology, psychological, demographic, factors, predictors, personality, motivation, 
motivational climate, attitudes, intention
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Appendix B 
Summary and Reference of Included Studies 
Study Publication type Study 
design 
Context Sport type Age group Sample 
size 
Risk of 
bias 
Variables included in analyses 
Chng & Moore, 1990 Journal article CS Gym users Mixed Adults 222 Low Beh, Sex. 
CDC1, 1991 Dataset CS Students n/a Adolescent 6,280 Low Beh, Sex, Age. 
CDC1, 1993 Dataset CS Students n/a Adolescent 8,211 Low Beh, Sex, Age. 
Brower et al., 1994 Journal article CS Gym users Individual Adults 134 Potential Beh, DopeFrd. 
CDC1, 1995a Dataset CS Students n/a Adults 2,896 Low Beh, Sex, Age. 
CDC1, 1995b Dataset CS Students n/a Adolescent 5,483 Low Beh, Sex, Age. 
Nilsson, 1995 Journal article CS Students n/a Adolescent 1,383 Low Beh, Sex. 
Allemeier, 1996 Thesis CS Competitive 
Athletes 
Mixed Adults 182 Potential Int, Att, Norm, Self-Eff, Esteem, 
DisApp. 
Goldberg et al., 1996 Journal article Ex Students Team Adolescent 1,226 Low Beh, Int. 
Melia et al., 1996 Journal article CS Students n/a Adolescent 16,169 Low Beh, Sex. 
Vogels et al., 1996 Journal article CS Gym users Individual Mixed 330 Low Beh, Sex, DopeFrd. 
CDC1, 1998 Dataset CS Students n/a Adolescent 4,089 Low Beh, Sex, Age. 
Faigenbaum et al., 1998 Journal article CS Students Mixed Children 965 Low Beh, Sex, DopeFrd. 
CDC1, 1999 Dataset CS Students n/a Adolescent 7,808 Low Beh, Sex, Age. 
Kindlundh et al., 1999 Journal article CS Students n/a Adolescent 2,742 Low Beh, Sex. 
Goldberg et al., 2000 Journal article Ex Students Team Adolescent 2,516 Low Beh, Int. 
CDC1, 2001 Dataset CS Students n/a Adolescent 6,925 Low Beh, Sex, Age. 
         
P a g e  | 50 
 
Study Publication type Study 
design 
Context Sport type Age group Sample 
size 
Risk of 
bias 
Variables included in analyses 
Pedersen & Wichstrøm, 
2001 
Journal article CS Students n/a Adolescent 10,828 Low Beh, Sex. 
Miller et al., 2002 Journal article CS Students n/a Adolescent 16,175 Low Beh, Sex, Age. 
Goldberg et al., 2003 Journal article Ex Students n/a Adolescent 385 Low Beh. 
Laure et al., 2004 Journal article CS Students Mixed Adolescent 1,459 Low Beh, Sex, TeamSp. 
Lucidi et al., 2004 Journal article CS Students n/a Mixed 952 Low Beh, Int, Sex, Age, SupUse, Att, 
Norm, Self-Eff, Mor. 
CDC1, 2005 Dataset CS Students n/a Adolescent 7,160 Low Beh, Sex, Age. 
Dodge & Jaccard, 2006 Journal article CS Students Mixed Adolescent 14,322 Low Beh, Sex. 
Donahue et al., 2006 Journal article CS Competitive 
Athletes 
Mixed Mixed 1,201 Low Beh, Age, AutMot, ConMot, Mor. 
Kanayama et al., 2006 Journal article CS Gym users Individual Adults 89 Low Beh, Age, Esteem, Perf. 
Papadopoulos et al., 2006 Journal article CS Students Mixed Adults 2,173 Low Beh, Sex, SupUse. 
Striegel et al., 2006 Journal article CS Gym users Individual Adults 621 Low Beh, Sex. 
CDC1, 2007 Dataset CS Students n/a Adolescent 6,930 Low Beh, Sex, Age. 
Dodge & Jaccard, 2007 Journal article L Competitive 
Athletes 
Mixed Adults 301 Low Beh, Int, Sex, Att, Norm. 
Elliot et al., 2007 Journal article CS Students n/a Adolescent 14,997 Low Beh, Sex, Age. 
Laure & Bingsinger, 2007 Journal article CS Students n/a Children 3,594 Low Beh, Sex. 
Petróczi et al., 2007 Journal article CS Competitive 
Athletes 
Mixed Adults 199 Low Beh, Age. 
Wanjek et al., 2007 Journal article CS Students Mixed Mixed 2,313 Potential Beh, Sex, Age, Att. 
Al-Falasi et al., 2008 Journal article CS Gym users Individual Adults 153 Low Beh, Age. 
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Study Publication type Study 
design 
Context Sport type Age group Sample 
size 
Risk of 
bias 
Variables included in analyses 
Dodge & Jaccard, 2008 Journal article CS Competitive 
Athletes 
Team Adolescent 241 Potential Beh, Int, Sex, Age, Att, Norm. 
Lucidi et al., 2008 Journal article Pr Students Mixed Adolescent 1,232 Low Beh, Int, Sex, Age, SupUse, Att, 
Norm, Self-Eff, Mor. 
Moran et al., 2008 WADA Report CS Competitive 
Athletes 
Mixed Adults 375 Low Beh, Sex, Age, DopeFrd, TeamSp, 
TaskCli, EgoCli, Att, TaskOri, 
EgoOri, Perf, SpConf. 
Petróczi et al., 2008 Journal article CS Students n/a Adults 142 Low Beh, Age, Att. 
Rees et al., 2008 Journal article CS Students n/a Adolescent 495 Low Int, Age, SupUse. 
Wiefferink et al., 2008 Journal article CS Gym users Individual Mixed 144 Potential Int, Att, Norm, Self-Eff, DisApp. 
CDC1, 2009 Dataset CS Students n/a Adolescent 8,239 Low Beh, Sex, Age. 
Dunn et al., 2009 Journal article CS Gym users Individual Adults 214 Low Beh, Int, Age, SupUse. 
Lugo, 2009 Thesis CS Students Mixed Mixed 208 Low Beh, Int, Sex, Age, Att, AutMot, 
ConMot, Amo, TaskOri, EgoOri, 
Esteem, DisApp. 
Ranby et al., 2009 Journal article Ex Competitive 
Athletes 
Team Adolescent 1,261 Low Beh, Int. 
Rodek et al., 2009 Journal article CS Gym users Individual Adults 27 Potential Beh, Age, Reli. 
Ip et al., 2010 Journal article CS Gym users Individual Adults 1,519 Potential Beh, Sex. 
Thorlindsson & 
Halldorsson, 2010 
Journal article CS Students n/a Adolescent 10,918 Low Beh, Sex. 
Zelli et al., 2010a Journal article Pr Students n/a Adolescent 864 Low Int, Att, DisApp. 
Zelli et al., 2010b Journal article L Students Mixed Adolescent 1,022 Low Int, Sex, Age, Att, Norm, Self-Eff, 
Mor.
Barkoukis et al., 2011 Journal article CS Competitive 
Athletes 
Mixed Mixed 1,035 Low Beh, Int, Sex, Age, AutMot, ConMot, 
Amo, TaskOri, EgoOri, Mor. 
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Study Publication type Study 
design 
Context Sport type Age group Sample 
size 
Risk of 
bias 
Variables included in analyses 
CDC1, 2011 Dataset CS Students n/a Adolescent 7,379 Low Beh, Sex, Age. 
Gucciardi et al., 2011 Journal article CS Competitive 
Athletes 
Mixed Mixed 670 Low Beh, Sex, Age, TeamSp, Att, Esteem, 
Thr, Mor. 
Neeraj et al., 2011 Journal article CS Competitive 
Athletes 
Mixed Adults 303 Potential Beh, Sex, DopeFrd. 
Petróczi et al., 2011 Journal article CS Competitive 
Athletes 
Not 
reported 
Adults 82 Low Beh, Sex, Age, Att, Norm. 
Uvacsek et al., 2011 Journal article CS Competitive 
Athletes 
Not 
reported 
Adults 82 Low Beh, Sex, Age, Att. 
Allahverdipour et al., 2012 Journal article CS Gym users Individual Mixed 253 Low Beh, Int, SupUse, DopeFrd, Att, 
Norm, Self-Eff. 
Pope et al., 2012 Journal article CS Gym users Individual Adults 231 Low Beh, Age. 
Backhouse et al., 2013 Journal article CS Competitive 
Athletes 
Mixed Adults 212 Low Beh, Sex, SupUse, Att, Norm. 
Chan et al., 2013 Unpublished 
manuscript 
CS Competitive 
Athletes 
Mixed Adolescent 410 Low Beh, Int, Sex, Att, Self-Eff, AutMot, 
ConMot, Amo. 
Tsorbatzoudis et al., 2013 Unpublished 
manuscript/ 
WADA Report 
CS Competitive 
Athletes 
Mixed Mixed 650 Low Beh, Int, Sex, Age, TeamSp, Att, 
Norm, Self-Eff, AutMot, ConMot, 
Amo, TaskOri, EgoOri, AntReg, 
Mor. 
Whitaker, 2013 Thesis CS Competitive 
Athletes 
Mixed Adults 726 Low Beh, Int, Sex, Age, Att, Norm, Will. 
Barkoukis et al., in press Journal article CS Competitive 
Athletes 
Mixed Adolescent 309 Low Beh, Int, Sex, Age, TeamSp, Att, 
Norm, Self-Eff, AutMot, ConMot, 
Amo, TaskOri, EgoOri, Mor. 
Note. 1CDC = Centers for Disease Control and Prevention. CS = Cross-sectional; Pr = Prospective; L = Longitudinal; Ex = Experimental. Beh = 
Behaviour; Int = Intention; SupUse = Legal supplement use; DopeFrd = Know friend who is doping; TeamSp = Team sports participation; 
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TaskCli = Task motivational climate; EgoCli = Ego motivational climate; Att = Attitudes; Self-Eff = Self-efficacy to refrain from doping; 
AutMot = Autonomous motivation; ConMot = Controlled motivation; Amo = Amotivation; TaskOri = Task achievement goal orientation; 
EgoOri = Ego achievement goal orientation; Esteem = Global self-esteem; Perf = Perfectionism; Reli = Religiousness; SpConf = Sport 
confidence; AntReg = Anticipated regret; Thr = Threat of being caught; Will = Willingness to dope; Mor = Morality; DisApp = Dissatisfaction 
with appearance or body image. 
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Appendix C 
Risk of Bias Assessment 
 
The risks of bias of included studies were assessed using the following criteria. For each 
criterion, the paper will be assessed as having a) no or low risk of bias, or b) potential risk of 
bias. 
 
For all studies 
Sampling: 
1. Participants are randomly selected 
2. Sample sizes are not inadequate 
3. Participants are representative of various demographic groups 
4. If some participants were excluded from the analyses, the exclusion is justifiable 
5. When group comparisons are made, participants are matched on other meaningful 
demographics 
Measures: 
6. Validated measures are used, or the authors have provided sufficient support of 
psychometric properties of measures they devised 
7. Measures used were clearly defined and is appropriate 
For studies using longitudinal/prospective designs 
8. Authors have examined whether dropouts is random or not (e.g., compared baseline 
variables of dropouts with those who stayed in the study) 
9. Dropout rates were not high, and missing data were treated appropriately 
For studies using experimental designs 
10. Allocation sequence generated to produce comparable groups 
11. Allocation was concealed 
12. Whether blinding was done; and if so, whether it was effective 
13. Outcome data for all outcomes were reported; incomplete outcomes due to attrition 
and exclusions were addressed 
14. No selective outcome reporting 
15. Other sources of bias 
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Risk of Bias Assessment of Individual Studies 
Study 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15
Chng & Moore, 1990 + + + + + + +         
CDC, 1991 + + + + + + +         
CDC, 1993 + + + + + + +         
Brower et al., 1994 − + − − + + +         
CDC, 1995a + + + + + + +         
CDC, 1995b + + + + + + +         
Nilsson, 1995 + + + + + + +         
Allemeier, 1996 + + + + + − +         
Goldberg et al., 1996 + + + + + + + + + + + + + + + 
Melia et al., 1996 + + + + + + +         
Vogels et al., 1996 + + + + + + +         
CDC, 1998 + + + + + + +         
Faigenbaum et al., 1998 + + + + + + +         
CDC, 1999 + + + + + + +         
Kindlundh et al., 1999 + + + + + + +         
Goldberg et al., 2000 + + + + + + + + + + + + + + + 
CDC, 2001 + + + + + + +         
Pedersen & Wichstrøm, 
2001 + + + + + + +         
Miller et al., 2002 + + + + + + +         
Goldberg et al., 2003 + + + + + + + + + + + + + + + 
Laure et al., 2004 + + + + + + +         
Lucidi et al., 2004 + + + + + + +         
CDC, 2005 + + + + + + +         
Dodge & Jaccard, 2006 + + + + + + +         
Donahue et al., 2006 + + + + + + +         
Kanayama et al., 2006 + + + + + + +         
Papadopoulos et al., 2006 + + + + + + +         
Striegel et al., 2006 + + + + + + +         
CDC, 2007 + + + + + + +         
Dodge & Jaccard, 2007 + + + + + + + + +       
Elliot et al., 2007 + + + + + + +         
Laure & Bingsinger, 2007 + + + + + + +         
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Petróczi et al., 2007 + + + + + + +         
Wanjek et al., 2007 + + + + + − +         
Al-Falasi et al., 2008 + + + + + + +         
Dodge & Jaccard, 2008 + + + + + − +         
Lucidi et al., 2008 + + + + + + + + +       
Moran et al., 2008 + + + + + + +         
Petróczi et al., 2008 + + + + + + +         
Rees et al., 2008 + + + + + + +         
Wiefferink et al., 2008 + + − + + + +         
CDC, 2009 + + + + + + +         
Dunn et al., 2009 + + + + + + +         
Lugo, 2009 + + + + + + +         
Ranby et al., 2009 + + + + + + + + + + + + + + + 
Rodek et al., 2009 + − + + + + +         
Ip et al., 2010 − + − − − + +         
Thorlindsson & 
Halldorsson, 2010 + + + + + + +         
Zelli et al., 2010a + + + + + + + + +       
Zelli et al., 2010b + + + + + + + + +       
Barkoukis et al., 2011 + + + + + + +         
CDC, 2011 + + + + + + +         
Gucciardi et al., 2011 + + + + + + +         
Neeraj et al., 2011 + + + + + + −         
Petróczi et al., 2011 + + + + + + +         
Uvacsek et al., 2011 + + + + + + +         
Allahverdipour et al., 2012 + + + + + + +         
Pope et al., 2012 + + + + + + +         
Backhouse et al., 2013 + + + + + + +         
Chan et al., 2013 + + + + + + +         
Tsorbatzoudis et al., 2013 + + + + + + +         
Whitaker, 2013 + + + + + + +         
Barkoukis et al., in press + + + + + + +         
Note. + No or low risk of bias; − Potential risk of bias
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Appendix D 
Forrest Plots of Facilitators/Inhibitors Versus Doping Intentions and Behaviors 
Figure D1. Forrest plot of facilitators of doping predicting doping intentions. 
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Figure D2. Forrest plot of inhibitors of doping predicting doping intentions. 
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Figure D3. Forrest plot of facilitators of doping predicting doping behaviors. 
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Figure D4. Forrest plot of inhibitors of doping predicting doping behaviors. 
 
